Breadcrumb
- Home
- Policy and Compliance
- Policy Topics
- NIH Fiscal Policies
- ICO Funding Policies and Considerations
Main navigation (Sidebar Template)
-
Policy & Compliance
-
Implementation of New Initiatives and Policies
-
NIH Grants and Funding Information Status
-
Common Forms for Biographical Sketch and Current and Pending (Other) Support
-
Simplified Review Framework for Most Research Project Grants (RPGs)
-
Revisions to the NIH Fellowship Application and Review Process
-
Updates to Finding NIH Funding Opportunities and Information
-
Updates to NIH Institutional Training Grant Applications
-
Reference Letters
-
Updated Application Forms and Instructions (FORMS-I)
-
NIH Grants and Funding Information Status
-
Grants Policy Statement
-
Notices of Policy Changes
-
Compliance & Oversight
-
Policy Topics
-
Animal Welfare (OLAW)
- Laws and Regulations
-
Welfare and Compliance Topics
-
Alternatives and NAMs
-
Cephalopods in Research
-
Collaborations
-
Departures from the Guide
-
Disaster Preparedness and Response
-
Enrichment and Social Housing Resources
-
Frequently Referenced Notices
-
Grant and Contract to Protocol Congruence Review
-
Protocol Review
-
Semiannual Program Review and Inspection
-
Vertebrate Animals Section
-
Zebrafish
-
Alternatives and NAMs
- Animal Welfare Assurance
-
Reporting Noncompliance
- Animal Welfare Training and Education
-
About Us
-
Animals in NIH Research
-
Why Animals are Used in Research
-
How Animals Have Helped Improve Public Health
-
Adoption/Rehoming/Retirement of Laboratory Animals after Research
-
Why Properly Designed Experiments are Critical to Animal Research and Advancing Public Health
-
Ensuring the Care of Research Animals
-
When Are Alternatives to Animals Used in Research
-
Why Animals are Used in Research
-
Clinical Trial Requirements for Grants and Contracts
-
NIH's Definition of a Clinical Trial
-
Decision Tool: Does Your Human Subjects Study Meet the NIH Definition of a Clinical Trial?
-
Is My Project a Clinical Trial, Basic Experimental Study Involving Humans (BESH), or an Observational Study Involving Humans?
-
Basic Experimental Studies Involving Humans (BESH)
-
Clinical Trial-Specific Funding Opportunities
-
Clinical Trial-Specific Review Criteria
-
Good Clinical Practice Training
-
Human Subjects System
-
Human Subjects and Clinical Trials Information Form
-
Posting Clinical Trial Informed Consent Forms
-
Protocol Templates for Clinical Trials
- Requirements for Registering & Reporting NIH-Funded Clinical Trials
-
Information about NIH Clinical Trial Stewardship
-
Training & Resources for NIH Clinical Trial Policies
-
NIH's Definition of a Clinical Trial
-
Communicating, and Acknowledging Federal Funding
-
Early Stage Investigator Policies
-
NIH Early Stage Investigators Policy
-
Determining Early Stage Investigator (ESI) Status
-
Early Stage Investigator Extensions
-
Early Stage Investigator Related Data
-
History of NIH Support for Early Career Investigators
-
Related Notices, Laws, Statements and Reports
-
List of Smaller Grants & Awards that Maintain ESI Status
-
NIH Early Stage Investigators Policy
-
Family-Friendly Initiatives
- Financial Conflict of Interest
- Foreign Interference
-
Human Subjects Research
- Definition of Human Subjects Research
- Pre-Award and Post-Award Processes for Projects Involving Human Subjects Research
- Certificates of Confidentiality
-
Clinical Trial Requirements for Grants and Contracts
-
Inclusion Policies for Human Subjects Research
-
Single IRB for Multi-Site or Cooperative Research
- Policies & Regulations for Human Subjects
-
Training & Resources for Human Subjects
- Inclusion Policies for Human Subjects Research
- Intellectual Property Policy
-
Lobbying Guidance for Recipient Activities
-
Natural Disasters
-
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
-
Applicant/Recipient COVID-19 Update History
-
Funding Opportunities Specific to COVID-19
-
NIH Implementation of OMB Memorandum M-20-26 “Extension of Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations” dated June 18, 2020
-
Review Process during COVID-19 Pandemic
-
The Impact of COVID-19 on the Research Community
-
Applicant/Recipient COVID-19 Update History
-
Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
- Next Generation Researchers Initiative
- NIH Fiscal Policies
-
Peer Review Policies and Practices
- Public Access
- Research Integrity
- Research Misconduct
-
Rigor and Reproducibility
-
Principles and Guidelines for Publishing Preclinical Research
-
Guidance: Rigor and Reproducibility in Grant Applications
-
Resources for Preparing Your Application
-
Training and Other Resources for Rigor and Reproducibility
-
Meetings and Workshops for Rigor and Reproducibility
-
Notices, Blog Posts, and References for Rigor and Reproducibility
-
Principles and Guidelines for Publishing Preclinical Research
-
Scientific Data Sharing: Policies and Access to Data
-
Data Management and Sharing Policy
-
Genomic Data Sharing Policy
-
Genomic Data Sharing Policy Overview
-
Developing Genomic Data Sharing Plans
-
About Institutional Certifications
-
Completing an Institutional Certification Form
-
Genomic Data Sharing Expectations by NIH Institute & Center
-
Data Submission and Release Expectations
-
Where to Submit Genomic Data
-
How to Register and Submit a Study in dbGaP
-
GDS IC Contacts
-
Genomic Data Sharing Policy Overview
- Other Sharing Policies
-
Accessing Data & Publications
-
Requirements for NIH Controlled-Access Data Repositories and Users
-
Accessing Scientific Data
-
Accessing Genomic Data from NIH Repositories
-
How to Request and Access Datasets from dbGaP
-
Using Genomic Data Responsibly Under the NIH Genomic Data Sharing Policy
-
Genomic Data User Code of Conduct
-
NIH Data Use Certification Agreement
-
Requirements for NIH Controlled-Access Data Repositories and Users
-
Which Sharing Policies Apply to My Research?
-
Data Management and Sharing Policy
-
Select Agent Information
-
Subawards
-
Submission Policies
-
Supporting a Safe and Respectful Workplace
-
Animal Welfare (OLAW)
-
Implementation of New Initiatives and Policies
ICO Funding Policies and Considerations
NIH uses a unified funding strategy when making funding decisions. A set of core tenets provide a framework for all institute, center and office (ICO) funding policies to support the most meritorious science, address health priorities, and support a robust biomedical workforce.
Looking for other institute, center, or office grants and funding information?
Visit our Institutes, Centers, and Offices page and browse our ICO profiles to discover each ICO's mission, interest areas, and funding practices.
Visit our Institutes, Centers, and Offices page and browse our ICO profiles to discover each ICO's mission, interest areas, and funding practices.
Core Tenets
- Align with the NIH's mission
- Prioritize scientific merit; ICOs should consider peer review information in its entirety
- Integrate a breadth of topics and approaches relevant to the ICO’s priorities
- Consider investigator career stage and promote sustainability of the biomedical research workforce
- Promote broad distribution and geographic balance of funding, considering the total amount and type of NIH funding already available to each investigator
- Align with the availability of ICO funds
These ICO-specific funding policies and considerations pages build on the agency-wide framework.
- NIH Brain Research Through Advancing Innovative Neurotechnologies® Initiative (BRAIN)
- Fogarty International Center (FIC)
- National Center for Advancing Translational Sciences (NCATS)
- National Center for Complementary and Integrative Health (NCCIH)
- National Cancer Institute (NCI)
- National Eye Institute (NEI)
- National Human Genome Research Institute (NHGRI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute on Aging (NIA)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Biomedical Imaging and Bioengineering (NIBIB)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Institute on Drug Abuse (NIDA)
- National Institute on Deafness and other Communication Disorders (NIDCD)
- National Institute of Dental and Craniofacial Research (NIDCR)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- National Institute of Environmental Health Sciences (NIEHS)
- National Institute of General Medical Sciences (NIGMS)
- National Institute of Mental Health (NIMH)
- National Institute on Minority Health and Health Disparities (NIMHD)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute of Nursing Research (NINR)
- National Library of Medicine (NLM)
- Office of Behavioral and Social Sciences Research (OBSSR)
- Office of Disease Prevention (ODP)
- Office of Research Infrastructure Programs (ORIP)
- Office of Strategic Coordination (OSC)
For technical issues E-mail OER Webmaster